Clinical Trials Browser

Phase 1/2 × Burkitt Lymphoma × Clofarabine × Clear all

Burkitt Lymphoma, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00691652 2019-11-27

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Phase 1/2 Terminated

2 enrolled 4 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00412243 2013-03-12

Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients

Phase 1/2 Completed

51 enrolled 5 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

MITCL

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients